TIDMINS
RNS Number : 7309A
Instem plc
04 February 2022
4 February 2022
Instem plc
("Instem" or "the Company")
Exercise of Options, PDMR Dealing, Issue of Equity and Total
Voting Rights
Instem plc (AIM: INS), a leading provider of IT solutions to the
global life sciences market, announces that it was notified on 2
February 2022 that certain Directors of the Company exercised share
options ("Share Options") over, in aggregate, 100,000 ordinary
shares of 10 pence each in the Company ("Ordinary Shares").
Subsequently, on 2 February 2022, certain Directors sold a
portion of the Ordinary Shares issued on the exercise of the Share
Options to finance the cost of exercise (where applicable) and
associated tax liabilities.
Details of the Directors who participated in the exercise of
Share Options and subsequent sale of Ordinary Shares are as
follows:
Exercise Resultant Resultant
price per interest interest
Ordinary in Ordinary in Ordinary
Share Shares Shares
Number of: (%)
Name of Director Share Options Ordinary
exercised Shares sold
Phil Reason 80,000(a) 40,000 Nil 770,714 3.46%
Nigel Goldsmith 20,000(b) 12,500 176p 10,000 0.04%
(a) In relation to options granted on 22 February 2018 and exercisable on or before 15 March 2022
(b) In relation to options granted on 7 February 2012 and
exercisable on or before 7 February 2022
Issue of Equity and Admission
Application will be made to the London Stock Exchange for the
admission of the 100,000 new Ordinary Shares to trading on AIM
("New Ordinary Shares"). Admission is expected to take place at
8.00 a.m. on 9 February 2022.
Total voting rights
Following the issue and allotment of the above New Ordinary
Shares, the Company's issued share capital comprises 22,289,856
Ordinary Shares. The Company does not hold any Ordinary Shares in
treasury. Therefore the total number of voting rights in the
Company is 22,289,856.
The figure of 22,289,856 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change of their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information, please contact:
Instem plc via Walbrook
Singer Capital Markets (Nominated Adviser
& Broker) +44 (0) 20 7496 3000
Peter Steel
Rachel Hayes
Alex Bond
Stifel Nicolaus Europe Limited (Joint
Broker) +44 (0) 20 7710 7600
Ben Maddison
Alex Price
Walbrook Financial PR +44 (0) 20 7933 8780
Tom Cooper instem@walbrookpr.com
Nick Rome
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management, Regulatory Submissions, Clinical Trial Acceleration,
and Informatics-based Insight Generation.
Instem solutions are in use by over 700 customers worldwide,
including all of the largest 25 pharmaceutical companies, enabling
clients to bring life enhancing products to market faster. Instem's
portfolio of software solutions increases client productivity by
automating study-related processes while offering the unique
ability to generate new knowledge through the extraction and
harmonisation of actionable scientific information.
Instem products and services address aspects of the entire drug
development value chain, from discovery through to market launch.
Management estimate that over 50% of all drugs on the market have
been through some part of Instem's platform during their
development.
To learn more about Instem solutions and its mission, please visit www.instem.com
Notification and public disclosure of transactions by persons
discharging managerial responsibilities ("PDMRs") and persons
closely associated with them
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Phil Reason
----------------------------- -----------------------------------------
2 Reason for the notification
------------------------------------------------------------------------
a) Position/status Chief Executive Officer and PDMR
----------------------------- -----------------------------------------
b) Initial notification Initial
/Amendment
----------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor
------------------------------------------------------------------------
a) Name Instem plc
----------------------------- -----------------------------------------
b) LEI 213800PILYUFNNROQX68
----------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
------------------------------------------------------------------------
a) Description of Ordinary shares of 10p each
the financial
instrument, type
of instrument
Identification GB00B3TQCK30
code
b) Nature of the 1. Exercise of Options
transaction 2. Sale of Ordinary Shares
----------------------------- -----------------------------------------
c) Price(s) and volume(s)
-------------------------- ----------
Price Volume(s)
-------------------------- ----------
1. Nil (exercise
price) 80,000
-------------------------- ----------
2. 745p 40,000
-------------------------- ----------
d) Aggregated information n/a - the exercise of options
over Ordinary Shares and the sale
of Ordinary Shares each completed
as single transactions
- Aggregated volume
- Price
e) Date of the transaction 2 February 2022
----------------------------- -----------------------------------------
f) Place of the transaction In respect of the exercise of
options over Ordinary Shares:
outside a trading venue
In respect of the sale of Ordinary
Shares: London Stock Exchange,
AIM Market (XLON)
----------------------------- -----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Nigel Goldsmith
---------------------------- -----------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Chief Financial Officer and PDMR
---------------------------- -----------------------------------------
b) Initial notification Initial
/Amendment
---------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor
-----------------------------------------------------------------------
a) Name Instem plc
---------------------------- -----------------------------------------
b) LEI 213800PILYUFNNROQX68
---------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
-----------------------------------------------------------------------
a) Description of Ordinary shares of 10p each
the financial
instrument, type
of instrument
Identification GB00B3TQCK30
code
b) Nature of the Exercise of Options
transaction
---------------------------- -----------------------------------------
c) Price(s) and volume(s)
-------------------------- ----------
Price(s) Volume(s)
-------------------------- ----------
1. 176p (exercise
price) 20,000
-------------------------- ----------
2. 745p 12,500
-------------------------- ----------
d) Aggregated information n/a - the exercise of options
over Ordinary Shares and the sale
of Ordinary Shares each completed
as single transactions
- Aggregated volume
- Price
e) Date of the transaction 2 February 2022
---------------------------- -----------------------------------------
f) Place of the transaction In respect of the exercise of
options over Ordinary Shares:
outside a trading venue
In respect of the sale of Ordinary
Shares: London Stock Exchange,
AIM Market (XLON)
---------------------------- -----------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHGIGDDLGGDGDS
(END) Dow Jones Newswires
February 04, 2022 03:08 ET (08:08 GMT)
Instem (LSE:INS)
Historical Stock Chart
From May 2024 to Jun 2024
Instem (LSE:INS)
Historical Stock Chart
From Jun 2023 to Jun 2024
